Mindfulness-Based Blood Pressure Reduction (MB-BP): Stage 1 single-arm clinical trial.

ABSTRACT:

Background and objectives

Impacts of mindfulness-based programs on blood pressure remain equivocal, possibly because the programs are not adapted to engage with determinants of hypertension, or due to floor effects. Primary objectives were to create a customized Mindfulness-Based Blood Pressure Reduction (MB-BP) program, and to evaluate acceptability, feasibility, and effects on hypothesized proximal self-regulation mechanisms. Secondary outcomes included modifiable determinants of blood pressure (BP), and clinic-assessed systolic blood pressure (SBP).

Methods

This was a Stage 1 single-arm trial with one year follow-up. Focus groups and in-depth interviews were performed to evaluate acceptability and feasibility. Self-regulation outcomes, and determinants of BP, were assesse

SUBMITTER: Loucks EB 

PROVIDER: S-EPMC6881004 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature